ZEN-3694 & Enzalutamide Combo Trial Now Recruiting

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

ZEN-3694 & Enzalutamide Combo Trial Now Recruiting

posted on Dec 06, 2016 04:31PM

Looks like patients are now being invited to dance in ZEN-3694/Enzalutamide Combo Therapy trial. First site, UCSF, now recruiting. Nice timing, with the AGM/Corporate update coming in about a week. Could be interesting......

A Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply